Holistic Management of a 55-Year-Old Female Patient with Chronic Obstructive Pulmonary Disease (COPD) and a History of Pulmonary Tuberculosis (TB) through a Family Medicine Approach at Pasar Ambon Primary Care Center
DOI:
https://doi.org/10.53089/medula.v14i7.1329Keywords:
Chronic obstructive pulmonal disease, family doctor, holistic management, pulmonary tuberculosisAbstract
Chronic obstructive pulmonary disease (COPD) is defined as a lung disease with clinical symptoms as shortness of breath, coughing, phlegm production due to airway abnormalities that cause persistent airflow obstruction. This airflow obstruction in COPD is progressive and often associated with chronic-inflammation caused by exposure to noxious substances, such as cigarette smoke. Tuberculosis (TB) is a contagious-infectious disease caused by Mycobacterium-tuberculosis and most often manifests in the lungs (pulmonary TB), although-M.Tb can also infect other organs (extrapulmonary TB). History of pulmonary TB could cause permanent-damage to lung-anatomy and associated with loss of lung-function, such as bronchiectasis, fibrosis, or post-TB emphysema, which can increase the risk of COPD. Research by Fan H et al in 2021 stated that there was a risk of COPD in patients with a previous history of pulmonary TB. Providing family doctor services rooted in evidence-based medicine involves the identification of risk factors and clinical issues, along with the management of patients, all within a patient centered and family oriented problem solving framework. This study involves a case-report-analysis. Primary data were gathered through history taking, physical examinations, and home visits. The evaluation is conducted based on a comprehensive diagnosis-spanning the initial, process-oriented, and final phases of the study, using both quantitative and qualitative methods. Interventions for the patient-consisted of educational measures for patients and their families using posters and direct discussions. Following these interventions, there was an observed improvement in both knowledge and behavioral-changes both patient and family-behaviors, as evidenced by improvements in the final holistic-diagnostics.
References
Antariksa B, Bahtiar A, Wiyono WH.. 2023. Penyakit paru obstruktif kronik (ppok) pedoman diagnosis dan penatalaksanaan di indonesia. Jakarta: PDPI.
Kemenkes RI. 2018. Laporan Nasional Riskesdas 2018. Jakarta: Kemenkes RI.
Naser F, Medison I, Erly. 2016. Gambaran Derajat Merokok Pada Penderita PPOK di Bagian Paru RSUP Dr. M. Djamil. Jurnal kesehatan andalas 5 (2): 306-11.
Kemenkes RI. 2020. Pedoman nasional pelayanan dokter tatalaksana tuberkulosis. Jakarta: Kemenkes RI.
Permenkes RI. 2016. Peraturan menteri kesehatan republik indonesia nomor 67 tahun 2016 tentang penanggulangan tuberkulosis. Jakarta: Kemenkes RI.
Fan H, Wu F, Liu J, Zeng W, Zheng S, Tian H, dkk. 2021. Pulmonary tuberculosis as a risk factor for chronic obstructive pulmonary disease: a systematic review and meta-analysis. Ann Transl Med. 9(5): 390.
Damayanti, A. 2014. Penyakit Paru Obstruktif Kronik Eksaserbasi Akut Pada Laki-Laki Lansia. 1(1): 1–23.
Nugraha, I. 2016. Hubungan Derajat Berat Merokok Berdasarkan Indeks Brinkman dengan Derajat Berat PPOK. 50: 1–23.
Paramasivan, K. 2017. Penyakit Paru Obstruksi Kronik (PPOK). Jurnal Ilmu Kesehatan Masyarakat. 46: 1–41.
Minov J, Bislimovska J, Vasilevska K. 2015. Course of COPD Assessment Test (CAT) Score During Bacterial Exacerbation on Chronic Obstructive Pulmonary Disease Treated in Outpatient Settings. Open Respiratory Medical Journal. 9(2): 3945.
Nungtjik AK, Mangunnegoro H, Yunus F. 2019. Efikasi pemberian kombinasi inhalasi salmeterol dan flutikason propionat melalui alat diskus pada penyakit paru obstruktif kronik. Maj Kedokt Indon. 60(12): 546-553.
Saftarina, F. 2019. Studi Fenomenologi Tentang Faktor Risiko Penularan Tuberculosis Paru di Perumnas Way Kandis Lampung. Jambi Medical Journal. 7(1): 8-18.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Medical Profession Journal of Lampung
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.